ArticleJournal for immunotherapy of cancer2025
Potent and durable control of mesothelin-expressing tumors by a novel T cell-secreted bi-specific engager.
Paris Kosti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it